Artemisia dracunculus essential oil
phytochemicalstudy, pre-treatment and co-treatment effectson morphine withdrawal syndrome
DOI:
https://doi.org/10.1590/Keywords:
Mice, Artemisia dracunculus, Morphine, Essential oilAbstract
Drug addiction is one of the most important global problems. Medicinal herbs have been traditionally used in the management and treatment of opioid withdrawal syndrome and pain. The aim of this study was to determine the effect of A. dracunculus essential oil in reducing the symptoms of morphine withdrawal in mice. Male mice (25-30 g) were randomly assigned into 4 groups (n=10). Morphine-dependent groups received morphine (50 and 75 mg/kg ip; three times/day, 3 days) and a single injection of morphine (50 mg/kg) and then naloxone on the fourth day via IP injection. The control group received saline. The post-treated group received morphine for 3 days; on the fourth day, ten minutes before receiving naloxone, A. dracunculus essential oil with a dose of 75 mg/kg was injected. All groups received naloxone 2 hours after receiving the last dose of morphine; then, the morphine withdrawal symptoms were measured for 30 minutes. In the post-treated and co-treated groups, the body stretching and shaking the claw were significantly less than morphine-dependent groups (p<0/05). Also, in the post-treated and co-treated groups, the blinking, itching, and the number of standing on two legs significantly decreased compared to the morphine group. Hence, it might be concluded that A. dracunculus essential oil can significantly reduce morphine withdrawal symptoms.
Downloads
References
Alipour P, Khodayar MJ, Mansouri MT, Ghorbanzadeh. Investigation on the effect of Ketotifen Upon morphine tolerance and dependence in mice. J Nat Pharm Prod. 2018; 13(3): 1-7.
Bown D. The Royal Horticultural Society encyclopedia of herbs & their uses. Dorling Kindersley Limited; 1995.
Duric K, Kovac-Besovic EE, Niksic H, Muratovic S, Sofic E. Anticoagulant activity of some Artemisia dracunculus leaf extracts. Bosn J Basic Med Sci. 2015; 15(2): 9-14.
Fraternale D, Flamini G, Ricci D. Essential oil composition and antigermination activity of Artemisia dracunculus (Tarragon). Nat Prod Commun. 2015; 10(8): 1469-72.
Fu W, Le Maître E, Fabre V, Bernard JF, David Xu ZQ, Hökfelt T. Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain. J Comp Neurol. 2010; 518(17): 3464-94.
Gholami M, Saboory E, Mehraban S, Niakani A, Banihabib N, Azad M-R, et al. Time dependent antinociceptive effects of morphine and tramadol in the hot plate test: using different methods of drug administration in female rats. Iran J Pharm Res. 2015; 14(1): 303-311.
Guimarães AG, Quintans JS, Quintans-Júnior LJ. Monoterpenes with analgesic activity-a systematic review. Phytother Res. 2013; 27(1): 1-15.
Health WHODoM, Abuse S, Organization WH, Board INC, Drugs UNOo Crime. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization; 2009.
Jain NK, Kulkarni SK. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J Ethnopharmacol. 1999; 68(1-3): 251-9.
Kavvadias D, Abou-Mandour AA, Czygan F-C, Beckmann H, Sand P, Riederer P, et al. Identification of benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their endogenous formation in plant tissue. Biochem Biophys Res Commun. 2000; 269(1): 290-295.
Kawata J, Kameda M, Miyazawa M. Cyclooxygenase-2 inhibitory effects of monoterpenoids with a p-menthane skeleton. Int J Ess Oil Therapeut. 2008; 2(4): 145-148.
Kerachian N, Alaee H, Gharavi-Naini M, Pilevarian A, Moghimi A. Effects of alcoholic extract of Avena sativa, Hypericum perforatum, Passiflora incarnata and Lavandula officinalis on symptoms of morphine withdrawal syndrome in rats. J Physiol Pharmacol. 2007; 10(4): 313-21.
Kordali S, Kotan R, Mavi A, Cakir A, Ala A, Yildirim A. Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A. dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils. J Agric Food Chem. 2005; 53(24): 9452-8.
Leal-Cardoso J, Matos-Brito B, Lopes-Junior J, Viana-Cardoso K, Sampaio-Freitas A, Brasil R, et al. Effects of estragole on the compound action potential of the rat sciatic nerve. Braz J Med Biol Res. 2004; 37(8): 1193-1198.
Maham M, Moslemzadeh H, Jalilzadeh-Amin G. Antinociceptive effect of the essential oil of tarragon (Artemisia dracunculus). Pharmaceutical. 2014; 52(2): 208-12.
Meysamie AP, Faramarzi B, Naieni KH. How addicts think about addiction and community problems? TUMJ. 2006; 64(5): 34-43.
Miladi-Gorgi H, Vafaei A, Taherian A, Vaezi T. The effects of aqueous extracts of Purtulaca oleracea on withdrawal syndrome in mice. J Med Plan. 2009; 4(29): 51-7.
Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nature reviews neuroscience. Nat Rev Neurosci. 2001; 2(2): 119-128.
Obistioiu D, Cristina RT, Schmerold I, Chizzola R, Stolze K, Nichita I, et al. Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris. Chem Cent J. 2014; 8(1): 1-11.
Obolskiy D, Pischel I, Feistel B, Glotov N, Heinrich M. Artemisia dracunculus L.(tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety. J Agric Food Chem. 2011; 59(21): 11367-84.
Ribnicky DM, Poulev A, O’Neal J, Wnorowski G, Malek DE, Jäger R, et al. Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods. Food Chem Toxicol. 2004: 42(4): 585-98.
Sayyah M, Nadjafnia L, Kamalinejad M. Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. J Ethnopharmacol. 2004: 94(2-3): 283-7.
Thakur ME. The American psychiatric publishing textbook of geriatric psychiatry. American Psychiatric Pub; 2015.
Zarrindast M-R, Rezayof A, Sahraei H, Haeri-Rohani A, Y. Rassouli. Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Brain Res. 2003; 965(1-2): 212-221.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
